REPROCELL Researchers Co-Author New Study Demonstrating the Potential of AI-Driven Drug Response Prediction for IBD Patients
01 June 2026
REPROCELL researchers co-author a study showing how AI and multi-omics can enhance drug response predictions for inflammatory bowel disease patients.